{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:33:41Z","timestamp":1790188421702,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11046-017-0190-0","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T09:13:48Z","timestamp":1502961228000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Aspergillus Bronchitis in Patients with Cystic Fibrosis"],"prefix":"10.1007","volume":"183","author":[{"given":"Claudia","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobst","family":"Roehmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Rickerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Melichar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-2857","authenticated-orcid":false,"given":"Carsten","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"190_CR1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16:45\u201356.","journal-title":"Nat Rev Genet"},{"key":"190_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biocel.2014.03.001","volume":"52","author":"SH Chotirmall","year":"2014","unstructured":"Chotirmall SH, McElvaney NG. Fungi in the cystic fibrosis lung: bystanders or pathogens? Int J Biochem Cell Biol. 2014;52:161\u201373.","journal-title":"Int J Biochem Cell Biol"},{"key":"190_CR3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/thoraxjnl-2012-202412","volume":"68","author":"CG Baxter","year":"2013","unstructured":"Baxter CG, Rautemaa R, Jones AM, et al. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum. Thorax. 2013;68:652\u20137.","journal-title":"Thorax"},{"key":"190_CR4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/apm.12253","volume":"122","author":"SM Nielsen","year":"2014","unstructured":"Nielsen SM, Kristensen L, S\u00f8ndergaard A, et al. Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients. APMIS. 2014;122:1007\u201312.","journal-title":"APMIS"},{"key":"190_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2013.02.003","volume":"12","author":"JC Liu","year":"2013","unstructured":"Liu JC, Modha DE, Gaillard EA. What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis? J Cyst Fibros. 2013;12:187\u201393.","journal-title":"J Cyst Fibros"},{"key":"190_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","volume":"47","author":"M Pihet","year":"2009","unstructured":"Pihet M, Carr\u00e8re J, Cimon B, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis\u2013a review. Med Mycol. 2009;47:387\u201397.","journal-title":"Med Mycol"},{"key":"190_CR7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/mmy\/myw035","volume":"54","author":"S Ziesing","year":"2016","unstructured":"Ziesing S, Suerbaum S, Sedlacek L. Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. Med Mycol. 2016;54:781\u20136.","journal-title":"Med Mycol"},{"key":"190_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12281-016-0268-z","volume":"10","author":"C Williams","year":"2016","unstructured":"Williams C, Ranjendran R, Ramage G. Pathogenesis of fungal infections in cystic fibrosis. Curr Fungal Infect Rep. 2016;10:163\u20139.","journal-title":"Curr Fungal Infect Rep"},{"issue":"560\u20136","key":"190_CR9","first-page":"e10","volume":"132","author":"CG Baxter","year":"2013","unstructured":"Baxter CG, Dunn G, Jones AM, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013;132(560\u20136):e10.","journal-title":"J Allergy Clin Immunol"},{"key":"190_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.130.1.222","volume":"130","author":"D Shoseyov","year":"2006","unstructured":"Shoseyov D, Brownlee KG, Conway SP, Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest. 2006;130:222\u20136.","journal-title":"Chest"},{"key":"190_CR11","first-page":"CD002204","volume":"11","author":"HE Elphick","year":"2016","unstructured":"Elphick HE, Southern KW. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev. 2016;11:CD002204.","journal-title":"Cochrane Database Syst Rev"},{"key":"190_CR12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.116.3.639","volume":"116","author":"DE Geller","year":"1999","unstructured":"Geller DE, Kaplowitz H, Light MJ, Colin AA. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Chest. 1999;116:639\u201346.","journal-title":"Chest"},{"key":"190_CR13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","volume":"70","author":"C Kosmidis","year":"2015","unstructured":"Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270\u20137.","journal-title":"Thorax"},{"issue":"Suppl 3","key":"190_CR14","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","volume":"37","author":"DA Stevens","year":"2003","unstructured":"Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: Cystic fibrosis foundation consensus conference. Clin Infect Dis. 2003;37(Suppl 3):S225\u201364.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"190_CR15","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S1569-1993(11)60012-X","volume":"10","author":"D Bilton","year":"2011","unstructured":"Bilton D, Canny G, Conway S, et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011;10(Suppl 2):S79\u201381.","journal-title":"J Cyst Fibros"},{"key":"190_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-8-73","volume":"8","author":"PD Khot","year":"2008","unstructured":"Khot PD, Ko DL, Hackman RC, Fredricks DN. Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis. 2008;8:73.","journal-title":"BMC Infect Dis"},{"key":"190_CR17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5114\/ceji.2015.56968","volume":"40","author":"E Swoboda-Kope\u0107","year":"2015","unstructured":"Swoboda-Kope\u0107 E, Go\u0142a\u015b M, Piskorska K, et al. Aspergillus galactomannan detection in comparison to real-time PCR assay in serum samples from high-risk group patients. Cent Eur J Immunol. 2015;40:454\u201360.","journal-title":"Cent Eur J Immunol"},{"key":"190_CR18","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1183\/09031936.01.00068901","volume":"18","author":"J Navarro","year":"2001","unstructured":"Navarro J, Rainisio M, Harms HK, et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European epidemiologic registry of cystic fibrosis. Eur Respir J. 2001;18:298\u2013305.","journal-title":"Eur Respir J"},{"key":"190_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","volume":"137","author":"R Amin","year":"2010","unstructured":"Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest. 2010;137:171\u20136.","journal-title":"Chest"},{"key":"190_CR20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thx.2011.161117","volume":"66","author":"K Boer de","year":"2011","unstructured":"de Boer K, Vandemheen KL, Tullis E, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66:680\u20135.","journal-title":"Thorax"},{"key":"190_CR21","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s10096-015-2474-y","volume":"34","author":"M Noni","year":"2015","unstructured":"Noni M, Katelari A, Dimopoulos G, et al. Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship. Eur J Clin Microbiol Infect Dis. 2015;34:2235\u201341.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"190_CR22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jcf.2016.01.004","volume":"15","author":"A Hector","year":"2016","unstructured":"Hector A, Kim T, Ralhan A, et al. Microbial colonization and lung function in adolescents with cystic fibrosis. J Cyst Fibros. 2016;15:340\u20139.","journal-title":"J Cyst Fibros"},{"key":"190_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2012.06816.x","volume":"1272","author":"A Chrdle","year":"2012","unstructured":"Chrdle A, Mustakim S, Bright-Thomas RJ, et al. Aspergillus bronchitis without significant immunocompromise. Ann N Y Acad Sci. 2012;1272:73\u201385.","journal-title":"Ann N Y Acad Sci"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-017-0190-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-017-0190-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-017-0190-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T08:10:26Z","timestamp":1516263026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-017-0190-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1007\/s11046-017-0190-0","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}